NCT04355858 2022-07-26
MULAN
Fudan University
Phase 2 Unknown
Clinical Trials
15 trialsNCT05438706 2022-06-30
A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer
Fudan University
Phase 2 Unknown
NCT02595320 2021-12-20
X7-7
University of Kansas Medical Center
Phase 2 Unknown
NCT01917279 2020-07-23
CAMELLIA
ChineseAMS
Phase 3 Unknown
NCT04380103 2020-05-08
A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
ChineseAMS
Phase 1/2 Unknown
NCT02007148 2019-02-27
MICADO
International Group of Endovascular Oncology
Phase 2 Unknown
NCT03588533 2018-07-17
HERZUMA-GC
Dong-A University Hospital
Phase 2 Unknown
NCT00482222 2013-01-23
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
University of Southampton
Phase 3 Unknown
NCT01126138 2011-05-04
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
ChineseAMS
Phase 3 Unknown
NCT01196455 2010-09-08
Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer
Croatian Cooperative Group for Clinical Research in Oncology
Phase 2 Unknown
NCT01195298 2010-09-06
Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
South Eastern European Research Oncology Group
Phase 2 Unknown
NCT00561522 2010-07-21
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
Fudan University
Phase 2/3 Unknown
NCT00580359 2008-01-08
S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT00324610 2006-05-18
Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Phase 1/2 Unknown
NCT00081536 2005-06-24
Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies
Aronex Pharmaceuticals
Phase 1/2 Unknown